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Introduction
Under various pathological conditions, including infection, 
malignancy, and autoimmune diseases, tissues are incessantly 
exposed to reactive oxygen species (ROS) produced by infi  ltrat-
ing infl  ammatory cells. We previously disclosed that superoxide 
stimulated cell motility in many types of malignant cells, leading 
to invasion and metastasis (Yoshizaki et al., 1994; Muramatsu 
et al., 1995; Tanaka et al., 1997, 2001; Kogawa et al., 1999). 
This notion is compatible with earlier fi  ndings that superoxide 
generated by red blood cells from sickle cell anemia patients 
stimulated transendothelial migration of human myeloid leuke-
mia, HL-60 cells, and human monocytes (Sultana et al., 1998) 
and that leukotriene B4 induced transmigration of human neutro-
phils across epithelium, which was inhibited by intracellular 
ROS scavenger N-acetylcystein (NAC) or NADPH oxidase in-
hibitor diphenylene iodonium (DPI; Woo et al., 2003). Further-
more, respiratory burst (superoxide generation) and prominent 
motility tracking to pathogens have been known to be pivotal 
features of infl  ammatory cells, in particular, monocytes/macro-
phages and neutrophils, and various chemokines that stimulate 
infl  ammatory cells to generate superoxide (Bokoch, 1995; Dang 
et al., 2001) have been shown to simultaneously evoke chemo-
taxis (Thelen, 2001), suggesting a close relationship between 
superoxide production and motility in these cells.
Cell motility results from remodeling of acto-myosin system, 
which is regulated by Rho family of small GTP-binding pro-
teins (Ridley, 2001). There is diversity in extracellular stimu-
lants for cell migration, such as lysophophatidic acid (Moolenaar 
et al., 2004), platelet-derived growth factor (Chiarugi et al., 2000), 
and hepatocyte growth factor (Kodama et al., 2000), and many 
different intracellular signaling molecules that correspond to 
each stimulant are implicated in the activation of RhoGTPases. 
However, despite the fact that superoxide and chemokines 
are considerably important as stimulants of motility, not only 
from the view of tumor biology but also from the view of innate 
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nder various pathological conditions, including 
infection, malignancy, and autoimmune diseases, 
tissues are incessantly exposed to reactive oxygen 
species produced by inﬁ  ltrating inﬂ  ammatory cells. We 
show augmentation of motility associated with morpho-
logical changes of human squamous carcinoma SASH1 
cells, human peripheral monocytes (hPMs), and murine 
macrophage-like cell line J774.1 by superoxide stimula-
tion. We also disclose that motility of hPMs and J774.1 
induced by a chemotactic peptide (N-formyl-methionyl-
leucyl-phenylalanine [fMLP]) was inhibited by superoxide 
dismutase or N-acetylcystein, indicating stimulation of 
motility by superoxide generated by fMLP stimulation. In 
these cells, protein kinase C (PKC) ζ was activated to 
phosphorylate RhoGDI-1, which liberated RhoGTPases, 
leading to their activation. These events were inhibited by 
dominant-negative PKCζ in SASH1 cells, myristoylated 
PKCζ peptides in hPMs and J774.1, or a speciﬁ  c inhibitor 
of RhoGTPase in SASH1, hPMs, and J774.1. These results 
suggest a new approach for manipulation of inﬂ  amma-
tion as well as tumor cell invasion by targeting this novel 
signaling pathway.
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  immunity, no detailed exploration on the motility relevant to 
these stimulants has been performed to date.
In the present study, we fi  rst reveal that, in human squa-
mous carcinoma SASH1 cells, superoxide activates PKCζ, 
which phosphorylates RhoGDI-1, in turn liberating RhoGT-
Pases from RhoGDI-1, leading to their activation. Then, using 
human peripheral monocytes (hPMs) and murine macrophage-
like cell line J774.1, we examined whether the superoxide 
extracellularly generated by hypoxanthine/xanthine oxidase 
(HPX/XOD), or which they themselves produced upon treat-
ment with a chemotactic peptide, N-formyl-methionyl-leucyl-
phenylalanine (fMLP), stimulated their motility, and found that 
both extracellularly generated and self-produced superoxide 
augmented their motility. Furthermore, we confi  rmed that the 
PKCζ–RhoGDI-1 phosphorylation–RhoGTPases activation 
signaling pathway was also involved in the motility of hPMs 
and J774.1 stimulated with superoxide or fMLP.
Results
Relevance of superoxide to motility 
of SASH1 cells
To examine the effect of superoxide on cell motility for SASH1 
cells, we performed a phagokinetic track assay (Fig. 1, a and b). 
The cells without any treatment showed some movement (in-
trinsic motility), which was not affected by the addition of 
Cu-Zn superoxide dismutase (SOD). When the cells were treated 
with HPX/XOD, the motility was enhanced as compared with 
that of nontreated cells. The enhancement of cell motility by   
superoxide stimulation was canceled with the addition of Cu-Zn 
SOD, indicating that superoxide by itself, not other types of ROS, 
is the factor that enhances the cell motility. Treatment of the 
cells with NAC resulted in almost complete suppression of 
intrinsic motility to the basal level, suggesting that endogenous 
ROS is affecting their motility. This effect of endogenous ROS 
on motility was not seen in Cu-Zn SOD transfectant (clone 1), 
suggesting that the endogenous ROS responsible for the cell mo-
tility is mainly superoxide. Incidentally, the suppressive effects 
observed in the other Cu-Zn SOD clones, including clone 2, 
were essentially the same as those seen in clone 1 (unpublished 
data). We also performed migration a assay. Cells treated with 
HPX/XOD showed higher motility than nontreated cells, and it 
was blocked by the addition of Cu-Zn SOD (Fig. S1 a, available 
at http://www.jcb.org/cgi/content/full/jcb.200607019/DC1).
To confi  rm that the motility of SASH1 cells is related to 
their intracellular ROS level, we analyzed dihydrorhodamine 
(DHR) 123 staining of SASH1 cells by FACS (Fig. 1 c). The 
nontreated SASH1 cells showed some staining intensity (endo-
genous ROS), which was not suppressed by extracellularly 
added Cu-Zn SOD. This staining intensity was clearly enhanced 
by treatment with superoxide. NAC pretreatment or Cu-Zn SOD 
overexpression suppressed the intensity to the basal levels and 
maintained the basal intensity even after superoxide treatment. 
Incidentally, extracellular superoxide was not detectable with 
this cell line measured by cytochrome c method (unpublished 
data), indicating that the cells were not releasing superoxide 
  extracellularly. These results suggest the relevance of superoxide 
to motility of SASH1 cells.
Superoxide reorganizes actin structure 
and activates Rho family GTPases 
in SASH1 cells
To investigate the mechanism of enhancement of cell motility 
by superoxide, we fi  rst examined the morphological changes in 
SASH1 cells (Fig. 2 a). The parental cells had a rather round 
shape with small lamellipodia. In the parental cell stimulated 
Figure 1.  Enhancement of cell motility by 
super  oxide. (a) On the photographs, bright 
  areas are phagokinetic tracks where the cells 
moved, absorbing gold colloidal particles. 
(b) Areas free of gold colloidal particles of 30 
individual cells were measured and shown 
as bar graphs. Graph shows cells with (open 
bars) or without (closed bars) 2 h of superoxide 
stimulation. Inserted ﬁ   gure shows immuno-
blotting of Cu-Zn SOD transduced SASH1 
cells. SOD indicates that 100 U/ml rhCu-Zn 
SOD was added in the medium, NAC indi-
cates that 40 mM NAC was added in the me-
dium, and clone 1 indicates SASH1 cells that 
were transfected with Cu-Zn SOD expression 
vector. *, P < 0.01, compared with the value 
without any treatment; **, P > 0.05, com-
pared with the value without any treatment. 
  Error bars indicate SEM. (c) SASH1 cells were 
treated as described in the ﬁ  gure, and intra-
cellular ROS level was monitored by DHR as 
ﬂ  uorescent probe. NAC indicates that 40 mM 
NAC was added in the medium 20 min before 
the assay, SOD expression (−) indicates Cu-Zn 
SOD transfectant without Cu-Zn SOD expres-
sion by adding tetracycline in the medium, 
and SOD expression (+) indicates SOD trans-
fectant with Cu-Zn SOD overexpression by re-
moving tetracycline from the medium.PHOSPHORYLATION OF RHOGDI-1 BY PKCζ • KURIBAYASHI ET AL. 1051
with superoxide, there was increment of F-actin and a more dis-
crete formation of lamellipodia and fi  lopodia than in that with-
out stimulation. Cu-Zn SOD transduced clone 1 showed less 
actin staining with spindle-shaped morphology (dendrite-like 
formation). Similar morphological features were observed with 
NAC-treated cells. This spindle-shaped morphology was un-
changed even after superoxide stimulation.
When we analyzed the activity of Rho family of small 
GTPases (Rho, Rac, and Cdc42) by pull-down assay, some acti-
vated forms of these proteins were identifi  ed in parental cells, and 
the superoxide stimulation apparently enhanced these proteins 
(Fig. 2 b). This activation of Rho family GTPases was markedly 
inhibited by overexpression of Cu-Zn SOD (Fig. 2 c). The 
  results of the pull-down assay were verifi  ed by analyzing the 
proteins relocalizing to the plasma membrane (Fig. S2, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200607019/DC1). 
RhoA, Rac1, and Cdc42 each showed an apparent membrane 
translocation followed by spontaneous detachment from the 
membrane in a relatively short time after superoxide treat-
ment; however, the detachment of Rac1was somewhat retarded 
compared with the other two GTPases.
Effects of inhibitors of Rho, Rac, 
and Cdc42 on the motility 
and morphological change relevant 
to superoxide in SASH1 cells
To verify the involvement of Rho, Rac, and Cdc42 in motility 
and morphological changes relevant to superoxide, we exam-
ined the effect of specifi  c inhibitors of the proteins on these 
  cellular events in SASH1 cells. Treatment with C3 substantially 
suppressed the motility of SASH1 cells down to the basal  levels, 
equivalent to that of NAC-pretreated cells, irrespective of 
superoxide stimulation.
Transfectants of dominant-negative (DN) Cdc42 (DNCdc42) 
and Rac1 (DNRac1), exhibited impaired motility similar to that 
of C3-treated cells treated with or without superoxide (Fig. 3 a). 
When the morphology of SASH1 cells was examined, treat-
ment with C3 resulted in a slight reduction of F-actin intensity 
(Fig. 3 d) compared with that of nontreated cells (Fig. 3 b) and 
showed new dendrite-like formations and multiple nuclei in a 
Figure 2.  Activation of Rho family GTPases 
by superoxide. (a) F-actin staining of SASH1 
cells, Cu-Zn SOD transfectants, and SASH1 
cells with 40 mM NAC pretreatment. Confo-
cal images of cells with or without 5 min of 
  superoxide stimulation are shown. Bars, 50 μm. 
(b) RhoGTPases activity of SASH1 cells with or 
without superoxide stimulation was analyzed 
by pull-down assay. (c) RhoGTPase activity 
of Cu-Zn SOD transfectants with or without 
  superoxide was analyzed by pull-down assay.
Figure 3.  Effect of inhibiting RhoGTPase activity on superoxide-induced 
cell motility and morphological change. (a) Phagokinetic track assay of 
SASH1 cells. Cont indicates SASH1 cells, C3 indicates SASH1 cells pre-
treated with 100 μg/ml C3 for 48 h, DNRac1 indicates DNRac1 trans-
duced SASH1 cells, and DNCdc42 indicates DNCdc42 transduced 
SASH1 cells. After 2 h with (open bars) or without (closed bars) superoxide 
stimulation, cell-moved areas were measured and shown as bar graphs. 
*, P < 0.01, compared with the value without any treatment. Error bars 
indi  cate SEM. (b–i) F-actin staining of the cells with or without 5 min of 
  superoxide treatment. (b and c) SASH1 cells; (d and e) SASH1 cells 
  pretreated with 100 μg/ml C3 for 48 h; (f and g) DNRac1 transduced 
SASH1 cells; (h and i) DNCdc42 transduced SASH1 cell. Bars, 50 μm.JCB • VOLUME 176 • NUMBER 7 • 2007  1052
single cell caused by inhibition of cytoplasmic division. In these 
cells, superoxide treatment did not increase F-actin intensity, 
but apparently induced lamellipodia or fi  lopodia formation (Fig. 
3 e). DNRac1 transfectant was not substantially different from 
the parental cells without the stimulation (Fig. 3 f), whereas 
superoxide treatment of the cells induced F-actin increment and 
fi  lopodia formation, although lamellipodia formation was not 
observed (Fig. 3 g). Transduction of DNCdc42 caused loss of 
cell polarity with relatively concentrated F-actin staining in the 
center of the cell (Fig. 3 h). The morphological characters of 
DNCdc42 became more apparent by treatment with superoxide 
(Fig. 3 i). These results are compatible with the previous notion 
that F-actin is regulated by Rho; that activation of Rac1 is as-
sociated with lamellipodia formation (Nobes and Hall, 1995), 
although it does not associate much with F-actin or fi  lopodia 
formation; and that Cdc42 regulates cell polarity and fi  lopodia 
(Etienne-Manneville, 2004).
Superoxide activates RhoGTPases via 
phosphorylation of RhoGDI-1 by PKC𝗇 
in SASH1 cells
As evidence that shows the relationship between PKC and 
RhoGTPases is accumulating (Hall, 1994; Balboa and Insel, 
1995; Machesky and Hall, 1996; Laudanna et al., 1998; Uberall 
et al., 1999; Coghlan et al., 2000; Mehta et al., 2001; Slater 
et al., 2001), we examined the possibility that PKC is a molecule 
that links superoxide with Rho family GTPases. The PKC 
  inhibitor, calphostin C, dose-dependently inhibited cell motility 
(Fig. 4 a) as well as the activity of Rho family GTPases (Fig. 
4 b) in superoxide-treated or nontreated SASH1 cells (Fig. 4, 
a and b). At 500 nM calphostin C, cell motility was suppressed 
to basal level and almost complete inhibition of the RhoGTPase 
activity was attained. The results suggested that PKC may be an 
upstream molecule of RhoGTPases and that it regulates cell 
motility stimulated by superoxide.
To determine which isozyme of PKC is responsible for the 
Rho family activation, we studied PKC isozymes that were ex-
pressed in SASH1 cells by immunoblotting and seven PKC iso-
zymes, PKCα, -β, -γ, -δ, -ε, -μ, and -ζ, were found to be 
expressed (Fig. 4 c, lane 1). As members of the Rho family of 
small GTPases form complexes with RhoGDI-1 in cytosol in 
their resting state and the fi  rst step of Rho family activation is 
their liberation from RhoGDI-1 (Ueda et al., 1990; Isomura 
et al., 1991; Chuang, et al., 1993; Hancock and Hall, 1993; Hart 
et al., 1998), we next identifi  ed the PKC isozyme that interacted 
with RhoGDI-1–RhoGTPases by pull-down assay using the 
anti–RhoGDI-1 antibody. As shown in Fig. 4 c, among seven 
isozymes expressed in SASH1 cells, only PKCζ was detected in 
the immunoprecipitates, and the association was enhanced 
by superoxide treatment. Furthermore, this coprecipitation of 
PKCζ with RhoGDI-1 was clearly inhibited in NAC-pretreated 
(Fig. 4 e) or Cu-Zn SOD transduced cells (Fig. 4 f), indicating 
dependency of PKCζ activation on superoxide stimulation. We 
then examined whether PKCζ kinase activity is stimulated in 
Figure 4.  Superoxide induces RhoGDI phos-
phorylation by PKC𝗇, leading to RhoGTPase 
liberation from RhoGDI. (a) After SASH1 cells 
were treated with calphostin C for 15 min, 
they were stimulated with (open bars) or with-
out (closed bars) superoxide for 2 h. Cell motil-
ity was measured and shown in the bar graph. 
*, P < 0 .01, compared with the value with-
out any treatment. Error bars indicate SEM. 
(b)   After 15 min of pretreatment of calphostin 
C, SASH1 cells were treated with or without 
  superoxide for 2 min, and RhoGTPase activity 
was measured by pull-down assay. (c, e, and f) 
SASH1 cells were treated with or without 
  superoxide, lysed, and subjected to IP using 
anti-RhoGDI antibody. The samples were then 
electrophoresed and immunoblotted by the 
anti  bodies indicated in the ﬁ  gures. Lane 1, 
positive controls; lane 2, without superoxide 
treatment; lane 3, 2 min of superoxide treat-
ment. (c) SASH1 cells; (e) SASH1 cells pre-
treated with 40 mM NAC for 20 min; (f) Cu-Zn 
SOD overexpressed SASH1 cells (clone 1). 
(d) Translocation assay of PKCζ in SASH1 cells 
treated with superoxide. 4 × 10
7 cells were 
treated with superoxide for the indicated times 
and subjected to subcellular fractionation. 
Plasma membrane fractions were electro-
phoresed and immunoblotted by the antibody 
indicated in the ﬁ  gure. (g) Activity of PKCζ was measured by its phosphorylation state as described in Materials and methods. SASH1 cells were pretreated 
by calphostin C of the concentrations indicated in the ﬁ  gure. (top) Phosphorylated PKCζ conﬁ  rmed by autoradiography; (bottom) immunoblotting of PKCζ 
to conﬁ  rm that an equal amount of the protein was loaded. (h) Superoxide phosphorylates threonine residue of RhoGDI. SASH1 cells with or without 2 min 
of superoxide stimulation were lysed and immunoprecipitated with anti-RhoGDI antibody. Immunoprecipitates were electrophoresed and immunoblotted by 
antibodies indicated in the ﬁ  gure. (i) Recombinant active PKCζ phosphorylated RhoGDI-1 immunoprecipitated from SASH1 cell lysate. In vitro kinase assay 
was performed as described in Materials and methods. (top) [
32P]RhoGDI-1; (bottom) RhoGDI-1 immunoblotting. (j) PKCζ associated with and RhoGTPases 
dissociated from RhoGDI after superoxide stimulation. SASH1 cells with or without superoxide treatment were subjected to IP by anti-RhoGDI antibody, and 
the samples were immunoblotted by the antibodies indicated in the ﬁ  gure.PHOSPHORYLATION OF RHOGDI-1 BY PKCζ • KURIBAYASHI ET AL. 1053
superoxide-treated cells. As shown in Fig. 4 g, phosphorylated 
PKCζ was increased in superoxide- treated cells as compared 
with nontreated cells revealed by in vitro phosphorylation assay. 
The PKCζ activity was suppressed by calphostin C in a dose-
  dependent manner as described previously (Xu and Clark, 1997; 
Furukawa et al., 1999; Fitzgerald et al., 2000; Liu et al., 2000). 
Further, PKCζ activation was confi  rmed by its translocation to 
the plasma membrane (Fig. 4 d). The PKCζ molecule consists of 
two functional domains, reportedly, a regulatory N-terminal 
  domain and a catalytic C-terminal domain (Spitaler and Cantrell, 
2004). We investigated which domain interacts with RhoGDI-1 
in superoxide-treated SASH1 cells by pull-down assay. As shown 
in Fig. S3 a (available at http://www.jcb.org/cgi/conent/full/jcb
.200607019/DC1), RhoGDI-1 did associate with the C-terminal 
catalytic domain but not with the N-terminal regulatory domain. 
The fact that PKC is a member of serine-threonine kinases, and 
RhoGDI-1’s interaction with the catalytic domain of PKCζ, 
prompted us to examine the possibility of phosphorylation of 
RhoGDI-1 by PKCζ. Immunoprecipitates with anti–RhoGDI-1 
antibody were found to contain threonine but not serine-phos-
phorylated RhoGDI-1 in both superoxide-treated and nontreated 
cells, though in the latter the threonine-phosphorylated RhoGDI-1 
increased more than in the former (Fig. 4 h).
To further elucidate whether PKCζ directly phosphorylate 
RhoGDI-1 upon superoxide stimulation or, rather, activates a 
putative kinase, which in turn phosphorylates RhoGDI-1, 
RhoGDI-1 was purifi  ed from SASH1 cell lysate by immuno-
precipitation (IP) and incubated with recombinant active PKCζ. 
As shown in Fig. 4 i, the intensity of the band representing 
[
32P]RhoGDI-1 in the PKCζ-treated preparation was apparently 
increased compared with that in the nontreated preparation, 
  indicating the direct action of PKCζ on RhoGDI-1.
On the other hand, when recombinant RhoGDI-1 was 
simply incubated with recombinant active PKCζ, phosphory-
lation of RhoGDI-1 was undetectable (unpublished data). 
Therefore, it is highly conceivable that some cofactors that 
  coprecipitated with RhoGDI from the cell lysate were required 
for RhoGDI-1 phosphorylation by PKCζ. The small RhoGT-
Pase family proteins are potential cofactors. Upon superoxide 
stimulation, PKCζ interacts with RhoGDI-1/small RhoGTPase 
family protein complex; binding of PKCζ to the complex stimu-
lates the release of the small RhoGTPases from RhoGDI (Fig. 
4 j). Incidentally, weak but nonnegligible phosphorylation of 
RhoGDI-1 observed in the PKCζ-nontreated preparation (Fig. 4 i, 
left) may be ascribed to the activity of endogenous PKCζ that 
has been coprecipitated with RhoGDI-1.
It is plausible that there is a kinase that phosphorylates 
RhoGDI downstream of PKCζ. To test this, recombinant active 
PKCζ was incubated with cell lysate to activate the putative kinase. 
PKCζ was subsequently removed by IP, and recombinant GST–
RhoGDI-1 was incubated with the lysate but was not phosphory-
lated by the PKCζ-defi  cient cell lysate (Fig. S3 b). The results 
denied the possibility of the other kinase downstream of PKCζ.
We then extended our investigation to examine the  kinetics 
of complex formation of RhoGDI-1 and Rho family GTPases 
or PKCζ by IP using anti–RhoGDI-1 antibody. An immuno-
reactive band of PKCζ increased in intensity from 30 s until 
2 min after superoxide treatment (Fig. 4 j). However, in the 
same time course, RhoGDI-1 showed no appreciable changes, 
whereas the bands of all Rho family GTPases showed gradual 
decrement, indicating the dissociation of RhoGTPases from the 
complex and their eventual activation upon initiation of  superoxide 
stimulation. These dissociation and association phenomena were 
not obvious in DNPKCζ transduced cells (Fig. 5 e).
Figure 5. DNPKC𝗇 inhibits superoxide-
  induced cell motility and Rho family GTPase 
activation.  (a) PKCζ activity of mock and 
DNPKCζ transfectants. (top) Autoradiography 
of phosphorylated PKCζ; (bottom) Immuno-
blotting of PKCζ. (b) After mock and DNPKCζ 
transfectants were stimulated with or without 
superoxide for 5 min, they were subjected to 
F-actin staining. Bars, 50 μm. (c) Motility of 
mock and DNPKCζ transfectants was studied 
and is shown in the bar graph. Cells without 
superoxide stimulation are indicated with 
closed bars, and cells with superoxide stimula-
tion are indicated with open bars. *, P < 
0.01, compared with the value without any 
treatment. Error bars indicate SEM. (d) Mock 
and DNPKCζ transfectants were stimulated 
with or without superoxide for 2 min, and 
RhoGTPase activity was studied by pull-down 
assay. (e and f) Mock and DNPKCζ transfect-
ants were subjected to IP by anti-RhoGDI anti-
body, and the samples were immunoblotted 
with the antibodies indicated in the ﬁ  gure.JCB • VOLUME 176 • NUMBER 7 • 2007  1054
DNPKC𝗇 inhibits superoxide-induced 
morphological change, Rho family GTPase 
activation, and motility of SASH1 cells
To further validate the implication of PKCζ in morphological 
changes, Rho family activation, and cell motility induced by 
  superoxide, SASH1 cells were transfected with DNPKCζ plasmid 
to suppress PKCζ activity. We fi  rst confi  rmed that the transfec-
tants expressed the DNPKCζ protein (unpublished data) and 
that DNPKCζ was truly active to inhibit autophosphorylation of 
PKCζ in vitro (Fig. 5 a). This DNPKCζ transfectant showed 
morphological features that were similar to those of the parental 
cells (Fig. 5 b), and these features were not apparently affected 
by superoxide treatment. Moreover, activation of Rho family 
proteins with superoxide stimulation was not seen in the 
DNPKCζ transfectants (Fig. 5 d). Furthermore, intrinsic cell 
motility or cell motility induced by superoxide was also im-
paired in the transfectant (Fig. 5 c). In the transfectant of 
DNPKCζ, the associations of RhoA, Rac1, and Cdc42 with 
RhoGDI were not affected (Fig. 5 e) and showed no increase of 
threonine phosphorylation of RhoGDI even after HPX/XOD 
treatment (Fig. 5 e). These results indicate that the activation of 
Rho family, the changes of cell morphology, and stimulation of 
cell motility relevant to superoxide were evoked by PKCζ.
Motility of J774.1 murine macrophage-like 
cell line is induced by superoxide through 
activation of PKC𝗇 and RhoGTPases
These observations led us to speculate that superoxide may be ac-
tively involved in the motility of infl  ammatory cells as well, most 
likely via an autocrine mechanism, as they are known to exhibit 
prominent motility and generate superoxide by themselves. We val-
idated this speculation by using macrophage-like cell line J774.1. 
As shown in Fig. 6 a, certain amount of superoxide was detected 
in the medium of the cells and their motility was signifi  cantly 
suppressed by addition of Cu-Zn SOD to the medium (Fig. 6 b), 
indicating autocrine stimulation of cell motility by superoxide 
released from the cells themselves (automotility). When the 
cells were treated with NAC, their motility (both auto and intrin-
sic) was almost completely suppressed (Fig. 6 b), indicating that 
not only automotility but also intrinsic motility is mediated by 
ROS inside the cells. Enhancement of the motility was clearly 
observed with the cells treated with superoxide. This enhanced 
motility was blocked by the addition of Cu-Zn SOD to the level 
of the cells treated with Cu-Zn SOD alone and to the basal level 
by NAC, suggesting that the effect of extracellularly added 
  superoxide is also operating intracellularly as ROS. These results 
were compatible with the morphological fi  ndings (Fig. 6 c). 
When nontreated cells are compared with NAC-treated cells, 
which resemble Cu-Zn SOD transfected SASH1 cells, F-actin 
increment, small but apparent formation of fi  lopodia, and little 
lamellipodia were seen, supporting the speculation of autoactiva-
tion of cells by self-produced superoxide. The F-actin intensity, 
fi  lopodia, and lamellipodia formation seen in nontreated J774.1 
cells were further enhanced in superoxide-treated cells.
To confirm the involvement of RhoGTPases in the 
  superoxide-relevant motility of J774.1 cells, we conducted a pull-
down assay for these enzymes. As shown in Fig. 6 d, superoxide 
activated RhoA, Rac1, and Cdc42 in a time-dependent manner. 
Figure 6.  Superoxide stimulates motility 
through sequential activation of PKC𝗇, phos-
phorylation of RhoGDI, and RhoGTPases in 
J774.1 murine macrophage-like cell line. 
(a) The amount of superoxide produced by 
J774.1 cells was measured by cytochrome c 
method. Cells with (open bars) or without 
(closed bars) 2 min of superoxide treatment 
are shown. SOD indicates that 100 U/ml 
rhCu-Zn SOD was added in the medium. *, P < 
0.01. (b, e, f, and h) Motility of J774.1 cells 
with or without 2 h of superoxide stimulation. 
NAC indicates that 40 mM NAC was added 
in the medium. C3 indicates that the cells were 
pretreated with the indicated concentrations of 
C3 for 48 h. Cal C indicates that the cells were 
pretreated with the indicated concentrations of 
calphostin C for 15 min. (h) The cells are pre-
treated with either 50 μM control peptide or 
50 μM myr-PKCζp for 30 min *, P < 0.01, 
compared with the value without any treat-
ment; **, P > 0.05. (c) F-actin staining of 
J774.1 cells with or without superoxide stimu-
lation. Bars, 20 μm. (d) After the indicated 
times of superoxide treatment, RhoGTPase ac-
tivity of J774.1 cells was studied by pull-down 
assay. (g) J774.1 cells were pretreated with 
calphostin C of the concentrations indicated in 
the ﬁ  gure and stimulated with or without 2 min 
of superoxide, and RhoGTPase activity was 
studied. (i) J774.1 cells with the indicated 
times of superoxide treatment were subjected 
to IP using anti-RhoGDI antibody and immuno-
blotted with the antibodies indicated in the 
  ﬁ  gure. Error bars indicate SEM.PHOSPHORYLATION OF RHOGDI-1 BY PKCζ • KURIBAYASHI ET AL. 1055
Then, to evaluate whether the activation of these GTPases is as-
sociated with cell motility, we intended to examine the motility 
of the cells treated with specifi  c inhibitors for RhoA, Rac1, and 
Cdc42. However, transduction of DN RhoGTPases was not fea-
sible in this cell line; therefore, only C3 treatment was performed. 
As shown in Fig. 6 e, treatment with C3 at a concentration of 
5 μg/ml caused suppression of motility of both superoxide-treated 
and nontreated J774.1 cells to the basal levels, suggesting the de-
pendency of the motility on Rho. We next studied whether there 
is PKCζ involvement in this signaling pathway. Among PKCα, 
-β, -γ, -δ, -ε, -μ, and -ζ, only PKCζ associated with RhoGDI-1 
examined by pull-down assay using RhoGDI-1 antibody (un-
published data). To confi  rm the role of PKCζ in cell motility and 
RhoGTPase activation, J774.1 cells were treated with calphostin C. 
Both cell motility (Fig. 6 f) and RhoGTPase activation (Fig. 6 g) 
of superoxide-treated and nontreated cells were substantially 
suppressed to basal levels by 500 nM calphostin C. We used my-
ristoylated pseudosubstrate peptide of PKCζ (myr-PKCζp) to in-
hibit the enzyme activity. Motility of J774.1 cells with or without 
superoxide stimulation was impaired by myr-PKCζp compared 
with control peptide–treated cells (Fig. 6 h). The phenomena 
of association of PKCζ and dissociation of GTPases from the 
RhoGDI-1–GTPases complex upon superoxide stimulation found 
in SASH1 cells were also confi  rmed in this cell line (Fig. 6 i), 
and dissociation and association were inhibited by calphostin C 
(not depicted). As shown in Fig. S4 (available at http://www.jcb
.org/cgi/content/full/jcb.200607019/DC1), Rac2 was also activated 
by superoxide in J774.1 cells.
Motility of human peripheral blood 
monocytes is induced by superoxide 
through PKC𝗇–RhoGDI-1–RhoGTPases 
signal
We further extended our study by examining human mono-
cytes collected from the peripheral blood of a healthy volunteer. 
As shown in Fig. S5 a (available at http://www.jcb.org/cgi/content/
full/jcb.200607019/DC1), addition of Cu-Zn SOD signifi  cantly 
lowered the motility of hPMs, indicating autocrine activation 
of motility by superoxide, which they generated (automotility). 
Treatment with NAC almost completely suppressed their motil-
ity, a fi  nding consistent with that observed with J774.1. Aug-
mentation of motility by superoxide treatment was also observed 
with hPMs (Fig. S5 a), as was the case with SASH1 and J774.1, 
and the motility was positively related with superoxide produc-
tion (Fig. S5 b). Morphologically, NAC-treated hPMs showed 
spindle form with dendrite formation, whereas nontreated cells 
exhibited a rather round shape with slightly increased F-actin 
staining and formation of some small fi  lopodia (Fig. S5 c). Such 
F-actin staining or fi  lopodia formation of hPMs was further 
strengthened by treatment with superoxide (Fig. S5 c). As 
shown in Fig. S5 d, the activation of RhoGTPases by superoxide 
was also confi  rmed. Moreover, movement of hPMs treated with 
or without superoxide was strongly suppressed by C3 to the ba-
sal levels (Fig. S5 e). To investigate whether PKCζ is also 
  involved in the motility of hPMs, we pulled down the isozyme 
with anti–RhoGDI-1 antibody in the cells treated with or with-
out superoxide. Coprecipitation of PKCζ with RhoGDI-1 was 
clearly observed in cells treated with superoxide and seen with 
less intensity in those without superoxide (Fig. 7 a). RhoGDI-1 
was apparently phosphorylated, as revealed by immunoblotting 
using anti-phosphothreonine antibody in both superoxide- 
treated and nontreated hPMs, with much higher intensity in the 
former than the latter (Fig. 7 a). As shown in Fig. 7 b, PKCζ 
  kinase activity was increased by superoxide stimulation. To 
  examine the involvement of PKCζ in the motility of hPMs, the 
cells were treated with myr-PKCζp. As shown in Fig. 7 c, motil-
ity of both superoxide-stimulated and nonstimulated cells were 
almost completely suppressed to basal level by myr-PKCζp. 
The activation of RhoGTPases in hPMs was also clearly sup-
pressed by treatment with myr-PKCζp (Fig. 7 d). Association of 
Figure 7.  Superoxide stimulates motility 
through sequential activation of PKC𝗇, phos-
pho  rylation of RhoGDI, and activation of 
RhoGTPases in hPMs. (a) hPMs with or without 
2 min of superoxide stimulation were subjected 
to IP using anti-RhoGDI antibody and immuno-
blotted with the antibodies indicated in the 
ﬁ  gure. (b) PKCζ activity of hPMs before and 
after 2 min of superoxide stimulation. (top) 
Autoradio  graphy; (bottom) immunoblotting. 
(c) Phago  kinetic track assay of hPMs stimulated 
with (open bars) or without (closed bars) super-
oxide for 2 h. The cells were pretreated with 
50 μM myr-PKCζp or control peptide for 30 
min   before the assay. *, P < 0.01, compared 
with the value without superoxide stimulation. 
Error bars indicate SEM. (d) hPMs were pre-
treated with 50 μM of the indicated peptides, 
and RhoGTPase activity with or without 2 min 
of   superoxide stimulation was studied. (e) hPMs 
were subjected to IP using anti-RhoGDI anti-
body and immunoblotted with the antibodies 
indicated in the ﬁ   gure. (f) F-actin staining of 
hPMs pretreated with 50 μM myr-PKCζp or 
control peptide. Bars, 20 μm.JCB • VOLUME 176 • NUMBER 7 • 2007  1056
PKCζ with RhoGDI-1 upon superoxide stimulation and disso-
ciation of RhoGTPases from RhoGDI-1 were confi  rmed with 
hPMs as well (Fig. 7 e). The effect of myr-PKCζp on the mor-
phology of hPMs was further examined (Fig. 7 f). hPMs had 
a round shape with small fi  lopodia and mild F-actin staining. 
  Filopodia formation and F-actin staining were enhanced, and 
lamellipodia formation became evident by treatment with 
  superoxide. In myr-PKCζp–treated cells, fi  lopodia and lamelli-
podia formation were hardly seen and intensity of F-actin was 
rather weak compared with nontreated cells. The association of 
PKCζ with and dissociation of RhoGTPases from RhoGDI-1 
were impaired in myr-PKCζ–treated cells (unpublished data).
Response of J774.1 cells and hPMs 
to fMLP
To investigate the role of superoxide in the motility of mono-
cytes/macrophages that are stimulated by chemokine, we 
examined the superoxide generation (Fig. 8 a and Fig. S5 f) 
and motility (Fig. 8 b and Fig. S5 g) of J774.1 cells (Fig. 8) 
and hPMs (Fig. S5, f and g) treated with fMLP. fMLP treat-
ment substantially stimulated superoxide production by these 
cells (Fig. 8 a and Fig. S5 f). The motility of these cells treated 
with fMLP was signifi  cantly increased, and this increment was 
negated by the addition of Cu-Zn SOD, NAC, or DPI (Fig. 
8 b and Fig. S5 g), indicating that the motility of these cells 
is prompted by superoxide generated by themselves through 
|activated NADPH oxidase in an autocrine manner. When fMLP-
treated cells were treated with myr-PKCζp, the motility of the 
cells was totally suppressed to basal levels. Essentially the same 
results were obtained by migration assay (Fig. S1 b). Thus, it 
was suggested that PKCζ is directly activated by fMLP, which 
utilizes the same PKCζ–RhoGDI-1–GTPases signal pathway 
as superoxide.
Discussion
In various pathophysiological situations, such as infl  ammation, 
malignancy, arterial sclerosis, tissue damage, etc., cells in the 
lesion are incessantly exposed to ROS. In the present study, all 
the cells examined, which included human tongue cancer cell 
line SASH1, the murine macrophage-like cell line J774.1, and 
hPMs, became motile after superoxide treatment, suggesting a 
ubiquitous role of superoxide as a stimulator of cell motility. 
Furthermore, the fi  nding that the addition of Cu-Zn SOD to hPMs 
or J774.1 cells suppressed their motility, suggests that the auto-
motility of those cells is largely dependent on the superoxide, 
which they themselves generate, i.e., an autocrine stimulation 
of the motility by superoxide.
Regarding the motility of cancer cells (SASH1), the auto-
crine mechanism was not operating, as self-produced superoxide 
was not detectable. However, as they respond to exogenous 
  superoxide (HPX/XOD), it is suggested that cancer cells ac-
quire invasiveness and metastatic ability as a consequence of 
enhanced motility stimulated by the superoxide generated by 
infi  ltrating infl  ammatory cells in a paracrine manner in vivo. 
The observation that NAC treatment of hPMs and J774.1 or 
Cu-Zn SOD transfection to SASH1 cells almost completely 
nullifi  ed the motility of these cells implies the essentiality of 
  intracellular superoxide as a generator of cell motility at the 
basal level (intrinsic motility). This recognition of the essentiality 
of intracellular superoxide for cell motility is consistent with 
our previous observation that an inverse relationship existed 
  between intracellular Cu-Zn SOD activity and invasiveness of 
  tumor cells. We used a tetracycline regulation system for transient 
expression of Cu-Zn SOD, as it was previously reported that 
forced long-term expression of SOD gene brought about growth 
suppression of the transfectants (Liu et al., 1997). With respect 
to the mechanism whereby extracellular superoxide increases 
intracellular superoxide, penetration through cell membrane 
may be a possibility (Lynch and Fridovich, 1978; Gus’kova 
et al., 1984; Mao and Poznansky, 1992; Gomes et al., 1993), 
  although the proof remains to be established.
To substantiate the idea that superoxide induces motility, 
we investigated the underlying molecular mechanism. The fi  rst 
issue we addressed was whether, and to what extent, the Rho 
family of small GTP-binding proteins was involved in the signal 
transduction of superoxide-induced cell movement, as these 
proteins are well accepted as common mediators of the cell sig-
nals for various stimuli. RhoA, Rac1, and Cdc42 were each 
  activated by superoxide stimulation in all three cells examined. 
The motility of SASH1 cells was markedly suppressed by C3, 
DNRac1, and DNCdc42, with C3 limiting motility to basal lev-
els in hPMs and J774.1 cells. Together, these results indicate 
that ROS induces cell motility via Rho family GTPase activa-
tion. Furthermore, each single GTPase may be indispensable 
for the cell movement induced by superoxide.
Next, we searched for the molecule that may link the 
  superoxide signal with Rho family GTPases. It has been reported 
that stimulators of cell motility, such as lysophophatidic acid 
and insulin, activate both Rho family GTPases and PKC simul-
tane ously (Hall, 1994; Machesky and Hall, 1996). Translocation 
of RhoA to membrane and RhoA-dependent phospholipase D 
Figure 8.  Response of J774.1 cells to fMLP. (a) Superoxide production 
of J774.1 cells treated with fMLP was measured by cytochrome c method. 
(b) Motility of J774.1 cells was measured by phagokinetic track assay. 
fMLP was added at 10 μM fMLP, SOD was added at 100 U/ml, NAC was 
added at 40 mM, DPI was added at 20 μM, control peptide was added at 
50 μM, and myr-PKCζp was added at 50 μM. Error bars indicate SEM.PHOSPHORYLATION OF RHOGDI-1 BY PKCζ • KURIBAYASHI ET AL. 1057
  activation induced by GTPγS are reportedly blocked by cal-
phostin C in MDCK cells (Balboa and Insel, 1995). Activation 
of RhoA by phosphorylating RhoGDI-1 by PKCα has been ob-
served in human umbilical venular endothelial cells stimulated 
with thrombin (Mehta et al., 2001). In addition to these reports, 
previous evidence indicating activation of PKCs by oxidative 
stress (Konishi et al., 1997; Klann et al., 1998) led us to hypoth-
esize that PKC is the linking molecule. This hypothesis was 
supported by the fact that calphostin C suppressed motility and 
activation of RhoGTPases in all three types of cells. With regard 
to the mechanism for activation of PKC by superoxide, the in-
volvement of PI3-kinase in linking these molecules is conceiv-
able because PI3-kinase has been known to activate PKCζ via 
PDK-1 phosphorylation in vitro (Chou et al., 1998). However, 
the fact that the inhibitor of PI3-kinase, LY294002, did not in-
hibit superoxide-induced RhoA or Cdc42 activation in our cells 
(unpublished data) negated this possibility. Thus, it seems likely 
that superoxide activates PKC either through activation of ki-
nases other than PI3-kinase or through direct activation of PKC 
by superoxide, possibly by causing conformational change 
 (Palumbo et al., 1992). Elucidation of these putative mechanisms 
remains a future task.
Given that PKC is involved in signaling from superoxide 
to all three RhoGTPases, it is highly plausible that PKC inter-
acts with RhoGDI-1 to activate RhoGTPases, because inactive 
RhoA, Rac1, and Cdc42 are commonly bound to RhoGDI-1. 
Therefore, using SASH1, J774.1 cells, and hPMs, we examined 
the direct interaction between PKCs and RhoGDI-1 by IP and 
found that only one specifi  c isozyme of PKCs, PKCζ, was co-
precipitable with RhoGDI-1. This observation, taken collec-
tively with the facts that treatment with DNPKCζ or inhibitory 
peptide of PKCζ caused suppression of motility and the activa-
tion of the GTPases, strongly supports the notion that this par-
ticular PKC isozyme is a signal transducer of superoxide.
It has been shown that peroxide activates various PKC 
isozymes expressed in COS cells (Konishi et al., 1997). We also 
found that superoxide treatment of SASH1 brought about acti-
vation of all types of PKCs expressed in the cell, as determined 
by their translocation to the plasma membrane. In this context, 
the specifi  c binding of PKCζ to RhoGDI-1 can be rationalized 
by the speculation that this isozyme has higher binding affi  nity 
than other PKC isotypes to the substrate (RhoGDI-1), and not 
by the specifi  c activation of PKCζ by superoxide.
It is generally accepted that for activation of RhoGTPases, 
their release from the RhoGDI-1 molecule is required. It was 
recently reported that PKCα, activated by thrombin, can phos-
phorylate RhoGDI-1, catalyzing the release of bound GTPases 
(Mehta et al., 2001). Our present results indicate that superoxide 
stimulates PKCζ, which in turn leads to RhoGDI-1 phosphoryl-
ation at threonine sites to liberate RhoGTPases. These results 
are compatible with the aforementioned study, except for the 
stimulant (superoxide) and signal transducer (PKCζ).
As infl  ammatory cells are usually attracted and activated 
by chemokines in the lesion, we further studied the role of 
  superoxide in motility of J774.1 and hPMs induced by fMLP, a 
chemotactic peptide that is known to interact with 7-transmem-
brane G-coupled formyl-peptide receptors (Le et al., 2002). 
Our fi   ndings that fMLP treatment of these cells stimulated 
  superoxide generation, which was suppressed by DPI, a specifi  c 
inhibi  tor of NADPH oxidase, confi  rmed the notion that chemo-
kines activate PKCζ to stimulate NADPH oxidase at plasma 
membrane, in turn generating superoxide (Bokoch 1995; Dang 
et al., 2001). On the basis of these fi  ndings, we extended our in-
vestigation to elucidate the relevance of fMLP-induced motility 
to superoxide generated by the cells treated with fMLP. The re-
sults that Cu-Zn SOD or DPI treatment suppressed the motility 
of J774.1 and hPMs support the concept of autocrine activation 
of chemokine-induced motility via superoxide. It was specu-
lated that NAC should scavenge out intracellular superoxide 
and thereby abrogate superoxide-induced cell motility. How-
ever, when the fMLP-stimulated J774.1 cells or hPMs were pre-
treated with NAC, a certain magnitude of motility unexpectedly 
remained. The results therefore imply that fMLP interaction 
with chemokine receptor stimulates multiple pathways to activate 
cell motility. Furthermore, the fact that myr-PKCζp suppressed 
the motility of J774.1 cells and hPMs to basal level suggests the 
possibility that the other signal (as well as superoxide-relevant 
one) is also mediated by PKCζ. This notion, activation of PKCζ 
through interaction of chemokine with its receptor, is veritably 
compatible with the recent report that atypical PKCζ regulates 
stromal cell–derived factor-1 mediated migration of human 
CD34+ progenitor cells (Petit et al., 2005). Hence, it may be 
reasonable to deduce that fMLP binds its receptors to activate 
PKCζ to generate superoxide, which in turn stimulates the mo-
tility in an autocrine manner via the PKCζ–RhoGDI-1–RhoGT-
Pase pathway. On the other hand, PKCζ activated by fMLP 
simultaneously induces motility via the common PKCζ–
RhoGDI-1–RhoGTPase pathway. Accordingly, the motility in-
duced by chemokine is considered to be at least partly dependent 
on superoxide.
In conclusion, we disclosed that superoxide plays a piv-
otal role in the motility of SASH1, J774.1, and hPMs through a 
novel signaling pathway of PKCζ–RhoGDI-1–RhoGTPases. 
Thus, these results suggest a new approach for manipulation of 
infl  ammation as well as tumor cell invasion by targeting this 
novel signaling pathway.
Materials and methods
Cells and cell culture
SASH1, a poorly differentiated human squamous cell carcinoma line was 
cultured in DME/F-12 (Invitrogen), and murine macrophage-like cell line 
J774.1 was cultured in RPMI (Invitrogen) supplemented with 10% FCS in 
humidiﬁ  ed 5% CO2 at 37°C. To attain the quiescent state, cells were cul-
tured in the medium without FCS for 20 h.
Culture of peripheral blood monocytes
CD14+ monocytes were isolated from peripheral blood mononuclear cells 
of healthy volunteers obtained by the standard Ficoll-Paque method and 
separated by negative magnetic depletion using hapten-conjugated CD3, 
CD7, CD19, CD45RA, CD56, and anti-IgE antibodies (MACS; Miltenyi 
Biotec) and a magnetic cell separator (MACS) according to the manufac-
turer’s instructions.
Superoxide and NAC treatment
Serum-starved cultures on 100-mm dishes were treated with 4 μg/ml HPX 
(Sigma-Aldrich) and 7 × 10
−3 U/ml XOD (Sigma-Aldrich) for various 
  incubation periods noted in each experiment. For NAC treatment, NAC JCB • VOLUME 176 • NUMBER 7 • 2007  1058
(Sigma-Aldrich) was dissolved in the medium, pH adjusted to 7.4, and the 
cells were treated for 1 h.
Measurement of phagokinetic tracks
A uniform carpet of gold particles was prepared as previously described 
(Albrecht-Buehler, 1977). In brief, sterilized coverslips were coated with 
1% bovine serum albumin and were placed in 35-mm tissue culture dishes. 
Gold colloidal solution (184 μM HAuCl4-4H20 and 11.6 mM Na2CO3) 
was boiled shortly to make gold colloidal particles, and the coverslips 
were coated with them. 2 × 10
3 serum-starved cells with various pretreat-
ments described in each experiment were seeded, attached to the cover-
slips, treated with or without superoxide, and 2 h later ﬁ   xed by 0.1% 
formaldehyde. The areas cleared of gold particles were examined under 
microscope and quantiﬁ  ed by image processing (KS400; Carl Zeiss Micro-
Imaging, Inc.).
Evaluation of intracellular ROS level
Intracellular ROS level was evaluated using DHR 123 (Invitrogen) as a ﬂ  uo-
rescent probe. After cells were treated with various conditions, as indi-
cated, 1 μl of 43.3 mM DHR was added to the cells suspended with 1 ml 
HBSS for 20 min, cells were washed, the generation of rhodamine 123 
was monitored on a FACScan (Becton Dickinson) with excitation at 488 nm, 
and the emitted ﬂ  uorescence was collected at 525 nm.
F-actin staining
The cells were ﬁ  xed in 3% paraformaldehyde for 20 min, permeabilized 
with 0.2% Triton X-100 for 5 min, and stained with rhodamine-labeled 
phalloidin (Invitrogen) for 40 min to visualize F-actin. Fluorescence images 
were obtained by a confocal laser-scanning microscope system with 40× 
objective lens (LSM5 PASCAL; Carl Zeiss MicroImaging, Inc.).
Preparation of recombinant Clostridium botulinum C3 exoenzyme 
and ADP-ribosylation assay
Preparation of recombinant C. botulinum C3 exoenzyme and ADP-ribosylation 
assay were performed as described previously (Morii and Narumiya, 
1995). The C3-expressing plasmid pET3a C3 was provided by S. Narumiya 
(Kyoto University Faculty of Medicine, Kyoto, Japan).
Immunodetection of RhoGDI-1–associated proteins
Cells were lysed in lysis buffer (20 mM Tris/HCl, pH 7.5, 10 mM MgCl2, 
1 mM pefabloc, 5 mM leupeptin, and 5 mM pepstatin) containing 1% 
NP-40 and were incubated with protein G–agarose beads (GE Health-
care) for 3 h to block the nonspeciﬁ   c binding. After centrifugation, the 
supernatant was incubated with anti–RhoGDI-1 antibody (Santa Cruz Bio-
technology, Inc.) for 3 h, followed by the addition of protein G–agarose 
beads, and agitated overnight. The beads were collected, washed, and 
further analyzed by immunoblotting. For immunoblotting, each aliquot of 
the sample was eluted by RhoGDI-1 peptide, mixed in SDS sample buffer, 
heated, separated on SDS-PAGE, and electroblotted. Antibodies against 
RhoA (26C4), RhoGDI-1, and PKCζ were purchased from Santa Cruz 
Biotechnology, Inc. Antibodies against Rac1 and PKCα, -β, -γ, -δ, -ε, -θ, 
and -μ were purchased from BD Biosciences. Antibodies against Cdc42 
were purchased from Upstate Biotechnology. Antibodies against phos-
phothreonine and phosphoserine were purchased from Zymed Labora-
tories and QIAGEN.
Rho family activation assay
Activity of Rho family small GTP-binding proteins was assayed by pull-
down assay using each assay kit (Upstate Biotechnology) according to the 
manufacturer’s instruction.
PKC𝗇 activity assay
PKCζ activity from 3 × 10
6 cells was assayed by assessing its phosphory-
lation state as described previously (Xu and Clark, 1997). In brief, PKCζ in 
cell lysates was immunoprecipitated with the anti-PKCζ antibody, washed, 
mixed in assay solution (35 mM Tris, pH 7.5, 15 mM MgCl2, 1 mM MnCl2, 
0.5 mM EGTA, 0.1 mM CaCl2, 1 mM sodium orthovanadate, and 100 μM 
γ-[
32P]ATP), and incubated at 30°C for 10 min. After reactions were 
stopped by the addition of gel loading buffer, the samples were boiled and 
analyzed by SDS-PAGE followed by autoradiography.
In vitro kinase assay for phosphorylation of RhoGDI
Phosphorylation of RhoGDI-1 in vitro was performed using RhoGDI-1 
  immunoprecipitated from SASH1 cell lysate with RhoGDI-1 antibody. Con-
ﬂ  uent cells grown in 100-mm dishes were washed with ice-cold PBS and 
lysed in IP buffer containing 50 mM Tris, pH 7.4, 150 mM NaCl, 0.25 mM 
EDTA, pH 8.0, 1% deoxycholic acid, 1% Triton X-100, 5 mM NaF, 1 mM 
sodium orthovanadate, 1 mM PMSF, 5 μg/ml leupeptin, 5 μg/ml apro-
tinin, and 1 μg/ml pepstatin A. The cells were collected and then cleared 
by centrifugation at 4°C at 14,000 g for 10 min. The lysate was incubated 
with anti–RhoGDI-1 antibody for 1 h followed by the addition of protein 
G–Sepharose beads overnight at 4°C. The beads were collected, washed 
twice with ice-cold lysate buffer, washed three times with PBS, and washed 
once with kinase buffer (8 mM MOPS, pH 7.4, and 0.2 mM EGTA). The 
immunoprecipitated RhoGDI-1 was incubated with 5 ng of recombinant 
active PKCζ in kinase assay buffer for 10 min at 30°C followed by the ad-
dition of magnesium/ATP cocktail (Upstate Biotechnology): 4 mM MgCl2 
and 25 μM ATP in 1 mM MOPS, pH 7.2, 1 mM β-glycerol phosphate, 0.2 
mM EGTA, 50 μM sodium orthovanadate, 50 μM dithiothreitol, and 
10 μCi γ-[
32P]ATP (stock 1 mCi/100 μl: 3,000 Ci/mmol; PerkinElmer). 
The reaction was stopped by the addition of Laemmli sample buffer. The 
samples were electrophoresed on a 10% SDS-polyacrylamide gel, trans-
ferred to nitrocellulose membrane, and exposed to x-ray ﬁ  lm. The blots 
were then subjected to Western blotting with anti–RhoGDI-1 antibody to 
verify that an equal amount of the protein loaded in each lane.
Subcellular fractionation
Cells were washed three times with ice-cold PBS and scraped in lysis buffer 
(20 mM Tris/HCl, pH 7.5, 10 mM MgCl2, 1 mM pefabloc, 5 mM leu-
peptin, and 5 mM pepstatin). The cells were lysed by 18 passes through a 
26-gauge needle on ice. Trypan blue staining of the lysate indicated 
>95% disruption of plasma membrane. The subcellular fractionation was 
performed by the method as described by Fleming et al. (1996). The lysate 
was ﬁ  rst centrifuged at 500 g for 10 min to prepare low-speed pellet, and 
the supernatant was recentrifuged at 120,000 g for 45 min to pellet the re-
mainder of the particulate fraction (high-speed pellet). The low-speed pellet 
was further puriﬁ  ed by sucrose gradient centrifugation to obtain plasma 
membrane fraction. Protein concentrations were determined using BCA 
protein assay (Pierce Chemical Co.) according to the manufacturer’s direc-
tions. Alkaline phosphodiesterase I, cytochrome c oxidase, and lactate de-
hydrogenase were used as marker enzymes for plasma membrane, 
mitochondria, and cytosol, respectively (Storrie and Madden, 1990). DNA 
and RNA were used as markers for nucleus and endoplasmic reticulum, re-
spectively, and were detected on agarose gels by ethidium bromide stain-
ing, with or without RNase treatment. After subfractionation of the cells, 
plasma membrane fractions were subjected for immunoblotting to measure 
PKC or RhoGTPase activity.
Cu-Zn SOD plasmid
The pTA-Hyg and pET2a vectors were provided by J. Yokota (National 
Cancer Center Research Institute, Tokyo, Japan). cDNA for the human 
Cu-Zn SOD expression vector was generated by PCR using the forward primer 
5′-T  T  T  C  C  G  T  T  G  C  A  G  T  C  C  T  C  G  G  A  A  -3′ and the reverse primer 5′-C  C  T  C  A  G-
A  C  T  A  C  A  T  C  C  A  A  G  G  G  A  -3′ with the human cDNA library as the template. 
The PCR fragment was ligated into the pET2a vector to generate pET2a 
Cu-Zn SOD vector, which expresses Cu-Zn SOD when tetracycline is omit-
ted from the medium. SASH1 cells were ﬁ  rst transduced with the pTA-Hyg 
vector, selected by hygromycin B, transfected with the pET2a Cu-Zn SOD 
vector, and selected by G418.
Plasmid for DNRac1 and DNCdc42
cDNA of N17Rac1 and N17Cdc42, which are DN cDNAs of Rac1 and 
Cdc42, were provided by Y. Takai (Osaka University, Osaka, Japan). 
N17Rac1 was first ligated into the pSVneo-Myc/Sra vector and 
then  cDNA coding for Rac1N17 tagged with Myc was digested and 
ligated into the pIRES/neo vector, resulting in pIRES-Rac1N17-Myc/neo. 
N17Cdc42 was ﬁ  rst ligated into the pFlag-CMV vector and then cDNA 
coding for N17Cdc42 tagged with Flag was digested and ligated into the 
pIRES/hyg vector, resulting in pIRES-Cdc42N17-Flag/hyg.
Plasmid for N- and C-terminal of PKC𝗇
cDNA coding for the N- or C-terminal of human PKCζ was generated by 
PCR with the human cDNA library as the template using the First strand 
cDNA Synthesis kit (Boeringer). To produce plasmid pRx-bsr-PKCζN that 
contains the N-terminal regulatory domain of human PKCζ (nucleotides 
1–738), we used 5′-C  C  G  G  A  A  T  T  C  A  C  C  C  A  A  G  A  T  G  G  A  A  G  G  G  A  G  C  G  G-
C  G  G  C  -3′ as the forward primer and 5′-C  G  C  G  G  A  T  C  C  T  C  A  T  A  G  G  T  C  A  A-
A  G  T  C  C  T  G  C  A  G  C  C  C  A  A  G  C  -3′ as the reverse primer. PCR products were 
separated, sequenced, digested with EcoRI and NotI, and ligated into 
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excised by HindIII and NotI. It was inserted into a retroviral vector, pRx-
bsr, supplied by H. Hamada (Sapporo Medical University, Sapporo, 
  Japan). We used pRx-bsr-PKCζN regulatory domain expressing vector as 
DN (DNPKCζ), as this domain reportedly showed autoinhibitory activity 
(Jaken, 1996).
To produce plasmid PKCζC that contains the C-terminal catalytic 
  domain of human PKCζ (nucleotides 739–1755), cDNA was generated by 
PCR using the forward primer 5′-C  C  G  G  A  A  T  T  C  A  A  T  C  A  G  A  G  T  C  A  T  C  G  G  G  C-
G  C  G  G  G  A  G  C  -3′ and the reverse primer 5′-C  G  G  G  G  T  A  C  C  T  C  A  C  A  C  C  G  A-
C  T  C  C  T  C  G  G  T  G  G  A  C  A  G  C  -3′. The PCR product was digested with EcoRI 
and NotI and ligated into a pcDNA3.1/V5-His (Invitrogen), and the frag-
ment containing (His)6 was excised by EcoRI and PmeI. The excised 
N-terminal PKCζ fragment was inserted into a retroviral vector, pRx-bsr, to 
construct PKCζC that contains the human C-terminal fragment of human 
PKCζ cDNA and (His)6. The plasmid of N- or C-terminal fragments of PKCζ 
was transfected into the ecotropic retroviral packaging cell line BOSC23 
by the calcium phosphate precipitation method to obtain the retroviral 
  supernatant. The amphotropic ψ Crip packaging cells were then infected 
with 2 ml of ﬁ  ltered retroviral supernatants of each plasmid in the presence 
of polybrene (Sigma-Aldrich).
Measurement of superoxide production
Phenol red–free medium was used in the assay. 10
6 cells were stimulated 
for 1 min with HPX/XOD, and the cells were further incubated for 1 h in 
the presence of 50 μM cytochrome c. The medium was removed and 
placed on ice, and the absorbance at 550 nm was immediately read by 
spectrophotometer with H20 as a blank. Superoxide-speciﬁ  c reduction of 
cytochrome c was expressed as the difference in absorbance between 
cells incubated with or without SOD using an extinction coefﬁ  cient  of 
21 mM
−1 cm
−1.
Peptides
Myr-PKCζp, S  I  Y  R  R  G  A  R  R  W  R  K  L  Y  R  A  N   (positions 113–129, which is pseudo-
substrate region of human PKCζ), and myr-control peptide, R  L  R  Y  R  N  K  R  I  W  R  S-
A  Y  A  G  R   (Laudanna et al., 1998), were custom made by Sawaday Technology 
Co. They were solubilized immediately before use at 1 mM concentration in 
PBS, pH 7.2, and heated at 40°C to achieve complete solubility.
Statistical analysis
Statistical analysis of data was performed by standard techniques with the 
aid of the Stat View computer program for the Macintosh (Abacus Con-
cepts). The means of values were provided with associated SEM. Statistical 
signiﬁ  cance was deﬁ  ned as P < 0.01.
Online supplemental material
Fig. S1 shows a migration assay of SASH1 cells and J774.1 cells. Fig. 
S2 shows translocation of Rho family small GTPases to plasma mem-
brane in SASH1 cells treated with superoxide. Fig. S3 shows the inter-
action of PKCζ catalytic domain with RhoGDI and that a SASH1 cell 
lysate without PKCζ did not phosphorylate recombinant RhoGDI-1. 
Fig. S4 shows activation of GTP-Rac2 by superoxide in J774.1 cells. 
Fig. S5 shows that superoxide stimulates RhoGTPases activity and motil-
ity of hPMs. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200607019/DC1.
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